Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
HIV Medicine|January 27, 2005
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patientsU H Iloeje, Y Yuan, G L'italien, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiencyKenneth A Lichtenstein, Carl Armon, Kate Buchacz, et al.JAMA|February 12, 1998
Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) InvestigatorsS D Holmberg, A C Moorman, J C Von Bargen, et al.AIDS (London, England)|April 26, 2000
Factors associated with the successful modification of antiretroviral therapy. HIV Outpatient Study InvestigatorsP J Weidle, K A Lichtenstein, A C Moorman, et al.Vaccine|December 28, 2013
Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010Thomas John Bender, Umid Sharapov, Okey Utah, et al.AIDS (London, England)|October 9, 2002
Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantificationPeter A Sklar, Douglas J Ward, Rose K Baker, et al.Annals of Internal Medicine|May 21, 2008
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003Pragna Patel, Debra L Hanson, Patrick S Sullivan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapyEllen M Tedaldi, Rose K Baker, Anne C Moorman, et al.The New England Journal of Medicine|March 27, 1998
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study InvestigatorsF J Palella, K M Delaney, A C Moorman, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2019
Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donorsJefferson M Jones, Brian M Gurbaxani, Alice Asher, et al.Pageof 11